Complex approach to the therapy of rare forms of dystonia

Cover Page


Cite item

Full Text

Abstract

Neurological manifestations of the disease in patients with rare forms of dystonia residing in Belarus are analyzed. Clinical variants of these dystonias and possible methods of their complex treatment are discussed. According to extensive long-term experience of the authors, optimal treatment of writer’s cramp, oromandibular dystonia, camptocormia, and segmentary and multifocal forms of dystonia should include different medications, injections of botulotoxin and physiotherapy.

 

About the authors

S. A. Likhachev

National Research Center of Neurology and Neurosurgery

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

T. N. Charnukha

National Research Center of Neurology and Neurosurgery

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

S. A. Navosha

Belarus State Medical University

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

V. F. Melnic

National Hospital of the Ministry of the Internal Affairs

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

A. V. Borisenko

National Research Center of Neurology and Neurosurgery

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

G. V. Zabrodzetc

National Research Center of Neurology and Neurosurgery

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

N. I. Charnenka

National Research Center of Neurology and Neurosurgery

Email: tatyana_ch@fromru.com
Белоруссия, Minsk

G. V. Zobnina

National Research Center of Neurology and Neurosurgery

Author for correspondence.
Email: tatyana_ch@fromru.com
Белоруссия, Minsk

References

  1. Антипова Л.Н., Катрич А.Н., Музлаев Г.Г. Опыт применения сонографического контроля инъекций ботулотоксина типа А. Фарматека 2007; 17: 83–87.
  2. Орлова О.Р., Яхно Н.Н. Применение Ботокса (БТА) в клинической практике. М.: Каталог, 2000.
  3. Тимербаева С.Л. Ботулинестический токсин типа А (диспорт) – новое слово в клинической нейрофармакологии. Фарматека 2007; 17: 40–46.
  4. Albanese A. EFNS guidelines on diagnosis and treatment of primary dystonias. J. Eur. J. Neurol. 2011; 18: 5–18.
  5. Brin M.F., Hallett M., Jankovic J. Scientific and therapeutic aspects of botulinum toxic. NY: Wilkins, 2002. 6. Caronni A., Bologna M., Rothwell J.C. et al. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov. Disord. 2011; 5: 100–102.
  6. Djebbari R., Montcel S., Sangla S. еt al. Factors predicting improvement in motor disability in writer’s cramp treated with botulinum toxin. J. Neurol. Neurosurg. Psychiatry 2004; 75: 1688–1691.
  7. Dressier D. Botulinum toxin therapy. Stuttgart: Thieme-Verlag, 2000.
  8. Evatt M.L., Freeman A., Factor S. Adult-onset dystonia. Handb. Clin. Neurol. 2011; 100: 481–511.
  9. Kevilj R., Mehuli C.K., Dundjer A. Temporomandibular disorders and bruxism. Minerva Stomatol. 2007; 56: 393–397.
  10. Moller E, Bakke M, Dalager T. et al. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity. Mov. Disord. 2007; 4: 785–790.
  11. Tan E.K., Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 1999; 53: 2102–2107.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Likhachev S.A., Charnukha T.N., Navosha S.A., Melnic V.F., Borisenko A.V., Zabrodzetc G.V., Charnenka N.I., Zobnina G.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies